Drug Wholesalers, Pathology Most Exposed to Higher Fuel Prices -- Market Talk

Dow Jones
Mar 24

2231 GMT [Dow Jones]--In healthcare, drug wholesalers and pathology specialists are most exposed to higher fuel prices stoked by the conflict in the Middle East. That's the view of Ord Minnett, which trims price targets on several stocks in Australia's healthcare sector, including Ebos, Paragon Care and Australian Clinical Labs. "We note that these businesses have freight and logistics operations (e.g. medicine supply, sample transportation) and a limited ability to pass on input costs near-term," analyst Tom Godfrey says. "As an example, Ebos is run-rating A$182 million of freight costs in FY26 (1% of revenue, 16% of opex)." Its price target on Ebos falls 3.3% to A$29.00/share. Ord Minnett cuts price targets on Paragon Care and Australian Clinical Labs by 5.7% and 8.3% to A$0.33/share and A$2.20/share, respectively. (david.winning@wsj.com; @dwinningWSJ)

 

(END) Dow Jones Newswires

March 23, 2026 18:37 ET (22:37 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10